Clinical Trials in New York

Showing 6801-6820 of 22,668 trials

Mapping the Phenotype in Adults With Phelan-McDermid Syndrome

NCT03426059

The protocol aims to comprehensively define the phenotype of Phelan-McDermid Syndrome and to identify potential genetic factors, which may play a role in the variability of the disease's outcomes. The first aim involves a physical exam, a neurological exam, collection of medical history information, a clinical genetic evaluation, blood work and neuropsychological assessments. If clinically indicated, the protocol collects information from medical tests. These medical tests may include electrocardiography, echocardiography, renal ultrasonography, and renal ultrasound.

Phelan-McDermid SyndromeAutism Spectrum DisorderIntellectual Disability

Boston Children's Hospital24 participantsStarted May 2018

Stanford, California, United States • Chicago, Illinois, United States • Bethesda, Maryland, United States +3 more locations

COMPLETEDNA< 1 mile

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

NCT03400150

The BioProtect Balloon Implant™ System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the balloon to reduce the radiation dose delivered to the anterior rectum. The balloon composed of a biodegradable material that maintains that space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient's body over time.

Prostate Cancer

BioProtect222 participantsStarted Jan 2018

Apple Valley, California, United States • Irvine, California, United States • Daytona Beach, Florida, United States +13 more locations

Mapping the Phenotype in Adults With Phelan-McDermid Syndrome

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

Find Trials by Condition in New York

Low GI Diet in Children and Adolescents With ALL

11C-PIB PET Study in MESA at Columbia University

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome

MCT for the Harvard/UCSF ROBIN Center

Neuroblastoma Precision Trial

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

A Safety, Tolerability, and Efficacy Study of BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis